AEMDライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (29 4月 2024 @ 22:30):

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States...

Stats
本日の出来高	768.00
平均出来高	8 122.00
時価総額	3.56M
EPS	$0 ( 2024-02-14 )
次の収益日	( $-1.180 ) 2024-06-26
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.270
ATR14	$0.0210 (1.54%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-16	Broenniman Edward G	Buy	32 894	Common Stock
2024-04-16	Rossetti Angela	Buy	32 894	Common Stock
2024-04-16	Shah Chetan	Buy	32 894	Common Stock
2024-04-16	Gikakis Nicolas	Buy	32 894	Common Stock
2024-03-29	Gikakis Nicolas	Sell	1 954	Common Stock

INSIDER POWER
77.19
Last 96 transactions
Buy: 2 829 634 \| Sell: 209 502

Aethlon Medical Inc 相関

10 最も正の相関
VCNX	0.971
MNRO	0.967
CAMP	0.965
SLDB	0.964
AAL	0.962
STIM	0.961
WOOF	0.961
QURE	0.961
ALLR	0.96
PHUN	0.96

10 最も負の相関
TIOA	-0.971
MSDA	-0.965
PRSR	-0.965
MCAA	-0.963
NESR	-0.962
FXCO	-0.96
ARYD	-0.96
BRIVU	-0.959
IGTA	-0.958
SKYA	-0.956

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Aethlon Medical Inc 財務諸表

Annual	2023
収益:	$574 245
総利益:	$-4.44B (-773 707.70 %)
EPS:	$-69.72

FY	2023
収益:	$574 245
総利益:	$-4.44B (-773 707.70 %)
EPS:	$-69.72

FY	2022
収益:	$294 165
総利益:	$139 948 (47.57 %)
EPS:	$-7.06

FY	2021
収益:	$659 104
総利益:	$0.00 (0.00 %)
EPS:	$-0.650

Financial Reports:

No articles found.

Aethlon Medical Inc

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.